Trial Profile
Phase II trial of intravenous Hep-114 in patients with toxic liver damage
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2015
Price :
$35
*
At a glance
- Drugs Hep 114 (Primary)
- Indications Liver injury
- Focus Therapeutic Use
- 06 Apr 2015 New trial record